Novartis - revenue 2019 by segment and market

This statistic reflects Novartis AG's revenue in 2019, distributed by segment and market. Swiss-based Novartis AG is one of the largest global pharmaceutical companies. In 2019, the Innovative Medicines division generated 76 percent of its revenue in established markets and 24 percent in emerging markets.

Percentage of Novartis AG's revenue in 2019, by segment and market*

Established marketsEmerging growth markets
Innovative Medicines76%24%
Sandoz73%27%
Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

January 2019

Region

Worldwide

Survey time period

2019

Supplementary notes

* Emerging Growth Markets comprise all markets other than the Established Markets of the US, Canada, Western Europe, Japan, Australia and New Zealand.

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Novartis"

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.